Correlation Between Posiflex Technology and Maxigen Biotech

Can any of the company-specific risk be diversified away by investing in both Posiflex Technology and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Posiflex Technology and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Posiflex Technology and Maxigen Biotech, you can compare the effects of market volatilities on Posiflex Technology and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Posiflex Technology with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Posiflex Technology and Maxigen Biotech.

Diversification Opportunities for Posiflex Technology and Maxigen Biotech

0.47

Correlation Coefficient

Posiflex Technology  Maxigen Biotech

Very weak diversification

The 3 months correlation between Posiflex and Maxigen is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Posiflex Technology and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and Posiflex Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Posiflex Technology are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of Posiflex Technology i.e., Posiflex Technology and Maxigen Biotech go up and down completely randomly.

Pair Corralation between Posiflex Technology and Maxigen Biotech

Assuming the 90 days trading horizon Posiflex Technology is expected to generate 1.53 times more return on investment than Maxigen Biotech. However, Posiflex Technology is 1.53 times more volatile than Maxigen Biotech. It trades about 0.18 of its potential returns per unit of risk. Maxigen Biotech is currently generating about 0.0 per unit of risk. If you would invest  12,000  in Posiflex Technology on September 12, 2024 and sell it today you would earn a total of  21,650  from holding Posiflex Technology or generate 180.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Posiflex Technology  vs.  Maxigen Biotech

Posiflex Technology

Risk-Adjusted Performance

25 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Posiflex Technology are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Posiflex Technology showed solid returns over the last few months and may actually be approaching a breakup point.

Maxigen Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Maxigen Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Posiflex Technology and Maxigen Biotech

The main advantage of trading using opposite Posiflex Technology and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Posiflex Technology position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.

The idea behind Posiflex Technology and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.